Conversely, infiltrating CD8+ T-cell levels in the tumor microenvironment were lower in patients with HBV-associated HCC compared with liver tissue from non-HBV HCC patients and healthy comparisons [40,47,69,71]. This evidence concerns the gene CD8A and hepatocellular carcinoma.